Edition:
United Kingdom

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

183.25USD
18 Oct 2018
Change (% chg)

$0.14 (+0.08%)
Prev Close
$183.11
Open
$182.80
Day's High
$187.19
Day's Low
$182.39
Volume
122,322
Avg. Vol
86,747
52-wk High
$205.99
52-wk Low
$121.89

Latest Key Developments (Source: Significant Developments)

Bio-Techne Signs Strategic Co-operation Agreement
Friday, 12 Oct 2018 

Oct 12 (Reuters) - Bio-Techne Corp ::BIO-TECHNE SIGNS STRATEGIC COOPERATION AGREEMENT WITH MICROPOINT BIOSCIENCE.BIO-TECHNE - CO, MICROPOINT BIOSCIENCE WILL FURTHER STRENGTHEN INTEGRATION OF MICROPOINT'S MICROFLUIDIC DIAGNOSTIC CHIP FOR POINT-OF-CARE TESTING.  Full Article

Bio-Techne Corp Completed Acquisition Of Exosome Diagnostics
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Bio-Techne Corp ::BIO-TECHNE CORPORATION COMPLETED ITS ACQUISITION OF EXOSOME DIAGNOSTICS, INC..  Full Article

Bio-Techne To Acquire Exosome Diagnostics Inc
Monday, 25 Jun 2018 

June 25 (Reuters) - Bio-Techne Corp ::BIO-TECHNE TO ACQUIRE EXOSOME DIAGNOSTICS, INC..BIO-TECHNE CORP - DEAL FOR $250 MILLION IN CASH PLUS CONTINGENT CONSIDERATION OF UP TO $325 MILLION DUE UPON ACHIEVEMENT OF CERTAIN FUTURE MILESTONES.BIO-TECHNE CORP - DEAL TO BE FINANCED USING CASH ON HAND & A REVOLVING LINE OF CREDIT FACILITY THAT CO EXPECTS TO OBTAIN PRIOR TO CLOSING OF DEAL.  Full Article

Bio-Techne Acquires Atlanta Biologicals Inc
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Bio-Techne Corp ::BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​.BIO-TECHNE - DEAL EXPECTED TO BE SLIGHTLY ACCRETIVE TO ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018.  Full Article

Bio-Techne releases Q1 adjusted earnings per share $0.90
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Bio-Techne Corp :Bio-Techne releases first quarter fiscal 2018 results.Q1 adjusted earnings per share $0.90.Q1 GAAP earnings per share $0.42.Q1 sales $144.6 million versus I/B/E/S view $142.9 million.Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Bio-Techne Q3 GAAP Earnings Per Share $0.52

* Q3 EARNINGS PER SHARE VIEW $1.14 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: